Ayahuasca, a traditional Amazonian brew, shows promising effects in psychological healing. In a study involving 200 participants, 70% reported significant reductions in anxiety and depression after consuming the brew. Biochemical analysis revealed that compounds in ayahuasca may enhance neural connectivity, potentially explaining its therapeutic benefits. These findings highlight ayahuasca's role in medicine and psychology, suggesting that psychedelics could be effective tools for mental health treatment. The vine's unique properties continue to intrigue drug studies, paving the way for future exploration.
Cannabis use doubles the risk of developing psychosis in vulnerable people, with the magnitude of risk linked to both the dose consumed and the age at first use. Gene-environment interactions further modulate this association. This review of 66 papers (23 cohort trials and 43 reviews) confirms a consistent relationship between cannabis consumption and increased psychosis risk in individuals without schizophrenia, though the exact mechanisms remain incompletely understood.